Immunofluorescence localization of prolyl 4-hydroxylase isoenzymes and type I and II collagens in bone tumours: type I enzyme predominates in osteosarcomas and chondrosarcomas, whereas type II enzyme predominates in their benign counterparts

scientific article

Immunofluorescence localization of prolyl 4-hydroxylase isoenzymes and type I and II collagens in bone tumours: type I enzyme predominates in osteosarcomas and chondrosarcomas, whereas type II enzyme predominates in their benign counterparts is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ACTHIS.2003.12.002
P8608Fatcat IDrelease_isyl3vjocfeftog5bkicrpy274
P698PubMed publication ID15147632

P2093author name stringTom Böhling
Helena Autio-Harmainen
Ritva Nissi
P433issue2
P921main subjectimmunofluorescence microscopyQ592324
chondrosarcomaQ1076087
P304page(s)111-121
P577publication date2004-01-01
P1433published inActa HistochemicaQ2690684
P1476titleImmunofluorescence localization of prolyl 4-hydroxylase isoenzymes and type I and II collagens in bone tumours: type I enzyme predominates in osteosarcomas and chondrosarcomas, whereas type II enzyme predominates in their benign counterparts
P478volume106

Reverse relations

cites work (P2860)
Q39599144An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α.
Q36859052Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome.
Q36840263Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?
Q42646226Proteomic analysis of mineralising osteoblasts identifies novel genes related to bone matrix mineralisation
Q33323281Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2.
Q43589203The Scandinavian Sarcoma Group: 30 years' experience

Search more.